Browse Category

Solutions

New Medical Solutions curates credible advances that solve real problems in healthcare—faster diagnosis, safer procedures, better monitoring, smoother coordination, and fairer access.

Lonza bets big on US growth, snaps up Merck KGaA’s CDMO business

Lonza will purchase the German Merck’s U.S.-based CDMO network for mid-triple-digit million euros. Besides five sites, the deal will bolster Lonza’s prowess in rapidly growing sectors such as cell and gene therapy,

November 3, 2026

News·Solutions

Hansoh, Samsung Biologics hit with FDA write-ups after inspections

In a pair of recently disclosed reports, the FDA outlined manufacturing concerns at separate facilities run by China’s Hansoh Pharma and Korea’s Samsung Biologics, with sterilization issues and data falsification among the

November 2, 2026

News·Solutions

Lonza rounds out Swiss ADC expansion’s scope with mid-scale capabilities

Several months after telegraphing a major antibody-drug conjugate manufacturing expansion in its native Switzerland, CDMO Lonza is laying out fresh details and growing the project’s scope.

October 29, 2026

News·Solutions

WuXi AppTec bucks DOD uncertainty through Q3, lifting forecast for 2026

As it continues to confront a potential existential threat in the United States, CRDMO juggernaut WuXi AppTec’s finances certainly don’t seem to be feeling the pressure.

October 27, 2026

News·Solutions

Esteve earmarks $80M to revamp CDMO operations in China

In the next phase of its global expansion, Esteve is set to invest $80 million in an upgrade and relocation of its CDMO business in China.

October 22, 2026

News·Solutions

FDA rebukes Baxter over ‘repeated’ production stumbles in new warning letter

The FDA rebuked Baxter in a lengthy warning letter that outlined a series of production violations that led to a trio of recalls earlier this year.

October 22, 2026

News·Solutions

Biopharma Companies Must Break the DMTA Linearity

Reimagining DMTA as a connected network gives scientists the flexibility to act when needed, with context retained across every decision

October 21, 2026

News·Solutions

Antheia lands $80M conditional loan from Trump administration to onshore drug manufacturing

The Department of War is allotting a conditional $80 million loan to next-gen ingredient maker Antheia, a move that will give the U.S. critical access to key starting materials and active pharmaceutical

October 20, 2026

News·Solutions

Par Health recalls more IV bags on cellulose risk weeks after similar action

Par Health issued a voluntary recall of two lots of the IV barbiturate Brevital sodium that may be tainted with cellulose.

October 12, 2026

News·Solutions

MedTech Intelligence Industry Survey Research Methodology

The MedTech Intelligence Industry Survey is a primary research initiative designed to capture the perspectives of professionals working across the medical technology sector. The study is intended to examine the pressures, priorities,

October 8, 2026

Solutions

1 2 3 … 26 Next

Go toTop